233 event(s) found
CNRC 2026
In French : "Le Congrès National des Réseaux de Cancérologie (CNRC) est un événement annuel majeur dans le domaine de la cancérologie, réunissant plus de 500 experts nationaux & régionaux, acteurs de la coordination des parcours de soins, professionnels de santé, associations de patients et représentants de l’industrie. Il permet de partager des connaissances, d’échanger sur les dernières avancées en matière de coordination, et de favoriser la collaboration entre les différents acteurs impliqués dans la prise en charge de patients atteints de cancer."
38th ENA (EORTC-NCI-AACR) Symposium on Molecular Targets and Cancer Therapeutics
Recognised as a leading forum for drug development and translational research, ENA 2026 will spotlight cutting-edge preclinical and phase I studies, fostering deep scientific exchange around emerging targets and novel therapeutics. Bringing together a global community of researchers, clinicians, and industry experts, the Symposium offers a dynamic platform to explore the latest breakthroughs in molecular biology, target identification, and drug innovation.
AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer
Conference on liver cancer biology, immunotherapy, and translational research.
AACR Special Conference in Cancer Research: Cancer Biology-informed Radioligand Therapy
The goal of this conference is to convene experts in cancer biology, immunotherapy, and radioligand therapy (RLT) to discuss approaches to treating cancer with radioligand therapies and explore synergies with other treatments. With significant effort and interest in radioligand therapy by academia, industry, and government, paradigm-changing studies have demonstrated that combining molecular imaging and RLT has the possibility to dramatically impact cancer treatment. However, the major limitation for the further development of this field is a lack of fundamental knowledge of the mechanism(s) of action of systemic therapeutic isotopes with tumors, the tumor microenvironment, and the immune system. This conference is needed to engage experts from these diverse areas to not only educate on the state-of-the-art in radiotheranostics, but also to leverage the knowledge of cancer biologists, clinical oncologists, and immunologists to understand how RLT approaches work and how to overcome their limitations to drive the development of next generation therapies. Advancing RLT requires multi-disciplinary effort, with critical input from experts in radiochemistry, instrumentation, nuclear physics, and radiation biology. An unmet need in the field is advanced understanding of systemic radiobiology and cancer immunology as linked to therapeutic isotopes to fill gaps in knowledge across these domains. This AACR conference will focus on bringing together experts in these areas to discuss: 1) novel mechanisms of action of how systemic beta- and alpha-emitting isotopes interact with tumors, TME and the whole body to affect cures; 2) how RLT engages the immune system to mediate therapeutic efficacy; 3) rational approaches to treating cancer with novel isotopes and repurposed radioligand therapies; and 4) novel combinations and synergies with targeted and cellular therapies as well as external beam radiation, leveraging the strengths of each. Understanding how RLT interacts with the TME and the immune system are key to advancing novel therapies to treat an array of cancers.
AACR Lung Cancer Conference
Conference on advances in lung cancer biology, diagnosis, and treatment.
TTLC 2027
TTLC 2027 organized by IASLC
AACR Special Conference in Cancer Research: Aneuploidy / Chromosomally Complex Cancers
Conference focusing on biology, pathogenesis, and therapeutic strategies for aneuploid and complex cancers.
AACR IO: Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy
Conference dedicated to immuno-oncology research, therapies, and translational applications.
2027 ASPHO Conference
Coming soon...
AACR Special Conference in Cancer Research: Advances in Radiation Biology Mechanisms: Towards Clinical Adoption
Conference on radiation biology mechanisms and translation to clinical oncology.
AACR Special Conference in Cancer Research: Cancer Dormancy and Residual Disease
Recent literature underscores that the biology of minimal residual disease (MRD) and tumor dormancy is distinct from that of established metastasis. Key unanswered questions include how DCCs evolve clonally at distant sites, the epigenetic and transcriptional programs that enforce dormancy, the role of organ-specific niches and immune surveillance and immune evasion, and the mechanisms by which dormant cells evade therapy and eventually reactivate. This second AACR conference focused on these topics will bring together basic scientists, clinicians, technology developers, and translational researchers to help catalyze the development of new strategies for tracking, targeting, and ultimately eradicating dormant cancer cells – transforming the prospects for true metastasis prevention and long-term cancer survival. Make plans to join us in Toronto for this exciting conference.
Inflammation and Cancer
Conference addressing the role of inflammation in cancer biology, prevention, and therapy.
SACO 2027
South African Congress of Oncology
SIOP 2027
Our SIOP 2027 Annual Congress will be held from 8 - 11 September, 2027 in Sydney, Australia. More information to follow closer to the congress year.
2027 World Conference on Lung Cancer
2027 World Conference on Lung Cancer organized by IASLC
20th AACR Conference on The Science of Cancer Health Disparities
Annual conference on cancer disparities, health outcomes, and strategies to reduce inequities.
AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics
Conference covering molecular targets, therapeutics, and translational research strategies.